Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,054,680
-$4,060,515 QoQ
Shares Held
22,000
-84.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#515
of 1,348 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,174,530
PutShares
24,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $53,156,493 across 8 Drug Manufacturers - General names. NVO ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
899,074 | $21,649,701 | |
| 2 | AMGN |
Amgen Inc
|
26,442 | $9,575,177 | |
| 3 | LLY |
ELI LILLY & Co
|
7,922 | $9,501,885 | |
| 4 | OGN |
Organon & Co.
|
554,800 | $7,511,992 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
48,515 | $2,795,434 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
22,000 | $1,054,680 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,405 | $694,542 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,953 | $373,082 |
All Filings in NVO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,054,680 | 22,000 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $1,174,530 | 24,500 | Put | Sole | 2026-08-13 | |
| 2026-03-31 | $5,115,195 | 139,189 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $14,229,600 | 387,200 | Put | Sole | 2026-05-14 | |
| 2025-12-31 | $23,099,520 | 454,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $254,400 | 5,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,745,000 | 500,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $2,913,225 | 52,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $2,902,016 | 52,298 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,106,040 | 15,928 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,698,189 | 31,367 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,488,324 | 20,898 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,251,258 | 8,766 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,227,632 | 9,561 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,179,640 | 11,403 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $747,435 | 8,219 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $369,943 | 2,286 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||